Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Equity Ratio (2020 - 2025)

Historic Equity Ratio for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to 0.34.

  • iSpecimen's Equity Ratio fell 1840.64% to 0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34, marking a year-over-year decrease of 1840.64%. This contributed to the annual value of 0.35 for FY2024, which is 4249.39% down from last year.
  • Per iSpecimen's latest filing, its Equity Ratio stood at 0.34 for Q3 2025, which was down 1840.64% from 0.1 recorded in Q2 2025.
  • iSpecimen's 5-year Equity Ratio high stood at 0.84 for Q2 2023, and its period low was 0.1 during Q2 2025.
  • In the last 5 years, iSpecimen's Equity Ratio had a median value of 0.65 in 2021 and averaged 0.61.
  • Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 11898.65% in 2021, then plummeted by 7985.45% in 2025.
  • Quarter analysis of 5 years shows iSpecimen's Equity Ratio stood at 0.83 in 2021, then decreased by 1.09% to 0.82 in 2022, then decreased by 25.36% to 0.62 in 2023, then crashed by 42.49% to 0.35 in 2024, then decreased by 3.56% to 0.34 in 2025.
  • Its Equity Ratio stands at 0.34 for Q3 2025, versus 0.1 for Q2 2025 and 0.24 for Q1 2025.